Other

Merck beats 1Q profit views with tight cost controls

Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, administration and research easily offset lower medicine sales outside the U.S.

Medications

Novartis profits dip as generic rival challenges cancer drug

Swiss pharmaceuticals maker Novartis says net income from continued operations fell 13 percent in the first quarter as generic competition cut into sales of Gleevec, one of the first very effective cancer medicines.

Psychology & Psychiatry

Anxiety can kill your social status

Neuroscientists at EPFL identify a brain region that links anxious temperament to low social status. The researchers were able to tweak social hierarchy in animals by using vitamin B3.

Addiction

Losing streak: Competitive high-school sports linked to gambling

The soft signs of compulsive gambling—high energy levels, unreasonable expectations, extreme competitiveness, distorted optimism and above-average IQs—are often the very traits that characterize competing athletes. However, ...

Other

New meds help drugmakers weather strong dollar, other issues

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...

page 9 from 16